A lysosomal channel emerges as a key regulator of lung fibrosis
A new study identifies the lysosomal cation channel TRPML1 as a critical regulator of extracellular matrix (ECM) degradation in the lung. The research shows that TRPML1 modulates the exocytosis of key matrix metalloproteinases (MMPs), including MMP2, 8, 9, 12, and 19, which are responsible for breaking down collagen and elastin. Loss of TRPML1 function, as seen in the lysosomal storage disorder mucolipidosis type IV (MLIV), leads to reduced MMP secretion from lung macrophages and fibroblasts, resulting in excessive collagen and elastin accumulation and a fibrosis-like phenotype in mice. Conversely, pharmacological activation of TRPML1 increases MMP levels, suggesting a potential therapeutic avenue for modulating ECM turnover.
Why it might matter to you: This work directly connects fundamental cell biology—specifically, lysosomal function and membrane trafficking—to a major pathological process. For cell biologists focused on organelle dynamics and protein degradation, it reveals a novel, physiologically critical role for a lysosomal channel in regulating extracellular proteolysis. The findings suggest that targeting TRPML1 could be a strategic approach for intervening in fibrotic diseases, shifting the focus from solely inhibiting collagen production to enhancing its degradation via controlled MMP release.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
